HBW Market News: VSI Focuses On First Offer, Nestle Invests In Consumer Health, Eosera Adds Products, Space, Staff
Executive Summary
Vitamin Shoppe discloses preliminary plan for shareholder vote on $208m takeover offer; Nestle Health Science invests in SpoonfulOne early childhood food allergy prevention brand; and ear care product firm Eosera moves to facility twice as large and adds two products, four staff members.
You may also be interested in...
Nestle Harvests Plant-Based Protein Firm Orgain As Latest US Nutrition Business Investment
Nestle Health Science has expanded its nutritional footprint steadily since 2017 but investing in Orgain, with option to fully acquire in 2024 brings its first business working exclusively with plant-based ingredients.
Nestle Pairs Nutrition Science Business With Pharma Firm Making Peanut Allergy Treatment
Nestle agrees to acquire Aimmune Therapeutics, maker of a drug indicated to reduce the severity of children’s allergic reactions to peanuts. It anticipates options to innovate in its consumer health children’s allergy business.
OTC Ear Care Firm Eosera Gets Earful From US FDA On Pain And Itch Remedies, GMP Compliance
Eosera has removed its Ear Pain MD and Ear Itch MD products from e-commerce pages on its website following FDA's warning letter. The warning identifying the pain and itch products as unapproved new drugs also states that a January inspection of the firm’s facility found GMP violations.